Josep Gámez

Also affiliated with Hospital General de Catalunya

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis”.

Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

Neurology(2023)10.1212/wnl.0000000000207937

N/A

0.652DataRank · unranked

76 citations

Jeffrey T. Guptill, Vera Bril, Josep Gámez, Sven G. Meuth, Richard J. Nowak +12 more

Confirmation of the Type 2 Myotonic Dystrophy (CCTG)n Expansion Mutation in Patients with Proximal Myotonic Myopathy/Proximal Myotonic Dystrophy of Different European Origins: A Single Shared Haplotype Indicates an Ancestral Founder Effect

UNC Libraries(2020)10.17615/gzep-km85

N/A

0DataRank · unranked

9 citations

Bjarne Udd, Richard T. Moxley, Fred A. Wright, B. Eymard, Armand Bottani +18 more

Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients

Neurology(2022)10.1212/01.wnl.0000903304.73134.e3

N/A

0DataRank · unranked

2 citations

Jeff Guptill, Carlo Antozzi, Vera Bril, Josep Gámez, Sven G. Meuth +8 more